KLP Kapitalforvaltning AS Buys New Position in Simulations Plus, Inc. (NASDAQ:SLP)

KLP Kapitalforvaltning AS purchased a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,100 shares of the technology company’s stock, valued at approximately $86,000.

Other institutional investors have also recently made changes to their positions in the company. Jones Financial Companies Lllp increased its holdings in Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock worth $34,000 after purchasing an additional 427 shares during the period. AlphaQuest LLC grew its position in shares of Simulations Plus by 502.9% during the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock worth $75,000 after buying an additional 2,243 shares in the last quarter. Quantbot Technologies LP increased its stake in shares of Simulations Plus by 191.6% during the fourth quarter. Quantbot Technologies LP now owns 5,371 shares of the technology company’s stock worth $150,000 after buying an additional 3,529 shares during the period. US Bancorp DE raised its holdings in Simulations Plus by 14.3% in the fourth quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock valued at $159,000 after acquiring an additional 713 shares in the last quarter. Finally, Olympiad Research LP purchased a new position in Simulations Plus in the fourth quarter worth approximately $211,000. Institutional investors and hedge funds own 78.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. KeyCorp raised their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a report on Friday, January 24th. StockNews.com raised Simulations Plus from a “sell” rating to a “hold” rating in a research report on Friday, April 4th. Finally, William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. Two equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $49.40.

Simulations Plus Stock Performance

Shares of SLP stock opened at $25.74 on Friday. The stock’s 50-day moving average is $28.94 and its two-hundred day moving average is $30.02. Simulations Plus, Inc. has a 1 year low of $23.01 and a 1 year high of $51.22. The firm has a market cap of $517.17 million, a price-to-earnings ratio of 64.35 and a beta of 1.13.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.25 by $0.06. The company had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The firm’s revenue was up 22.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.20 earnings per share. As a group, research analysts predict that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Insider Activity

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the sale, the director now directly owns 3,402,584 shares of the company’s stock, valued at $115,381,623.44. This represents a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 19.40% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.